Press Release

Crown Laboratories Announces New Chief Commercial Officer, John Peterson

JOHNSON CITY, TN (Apr. 8, 2019)—Crown Laboratories, Inc. (“Crown”), a leading, fully integrated global skin care company, announced today that John Petersen has joined the organization as Chief Commercial Officer, a new position that will oversee all global commercial operations for Crown’s Therapeutic, Beauty and Prescription Portfolios.

Mr. Petersen most recently was Head of Consumer Dermatology for Sandoz. Previously, his career included AstraZeneca, Galderma, L’Oréal USA and Alcon. Mr. Petersen has significant sales and marketing experience including oversight of trade sales, demand planning, supply chain, sales and marketing for consumer, OTC and prescription brands. He has managed best selling brands, such as Cetaphil.

“We are excited to have John join Crown to lead our very talented global commercial team,” said Jeff Bedard, President and CEO of Crown. “Throughout his career, John has focused on building partnerships and developing strategies that enhance the brands under his management.  We have built a diverse global portfolio that requires broad commercial expertise and John has significant experience in driving results and achieving corporate objectives.”

“I am thrilled to be joining the Crown team,” added John Petersen. “The vision that has been established, as well as the recent acquisitions, clearly put us on an exciting growth trajectory. I am looking forward to leading and helping the team exceed the goals set before us.”